It has been reported that MEK1/MAPK signaling was involved in a variety of cancers, such as lung cancer [29], pancreatic cancer [30], prostate cancer [31], melanoma [32] and colon cancer [33]. The gene discussed is MAP2K1; the disease is prostate cancer.